Purple Biotech (PPBT) Shares Outstanding (Weighted Average) (2016 - 2025)
Purple Biotech has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $904054.0 for Q4 2022.
- Quarterly Shares Outstanding (Weighted Average) fell 94.85% to $904054.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $904054.0 through Dec 2022, down 94.85% year-over-year, with the annual reading at $904054.0 for FY2022, 94.85% down from the prior year.
- Shares Outstanding (Weighted Average) was $904054.0 for Q4 2022 at Purple Biotech, down from $17.6 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $19.4 million in Q4 2019 and troughed at $140.0 in Q2 2019.
- The 5-year median for Shares Outstanding (Weighted Average) is $6.2 million (2020), against an average of $7.9 million.
- Year-over-year, Shares Outstanding (Weighted Average) soared 950.0% in 2018 and then crashed 94.85% in 2022.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $14.2 million in 2018, then soared by 36.34% to $19.4 million in 2019, then crashed by 40.62% to $11.5 million in 2020, then soared by 52.76% to $17.6 million in 2021, then crashed by 94.85% to $904054.0 in 2022.
- Per Business Quant, the three most recent readings for PPBT's Shares Outstanding (Weighted Average) are $904054.0 (Q4 2022), $17.6 million (Q4 2021), and $11.5 million (Q4 2020).